- Home
- AMZE vs ERNA Comparison
AMZE vs ERNA Comparison
Compare AMZE & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMZE
- ERNA
- Stock Information
- Founded
- AMZE 2019
- ERNA 2018
- Country
- AMZE United States
- ERNA United States
- Employees
- AMZE N/A
- ERNA N/A
- Industry
- AMZE Beverages (Production/Distribution)
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- AMZE Consumer Staples
- ERNA Health Care
- Exchange
- AMZE Nasdaq
- ERNA Nasdaq
- Market Cap
- AMZE 16.1M
- ERNA 13.5M
- IPO Year
- AMZE 2021
- ERNA N/A
- Fundamental
- Price
- AMZE $3.41
- ERNA $1.59
- Analyst Decision
- AMZE
- ERNA
- Analyst Count
- AMZE 0
- ERNA 0
- Target Price
- AMZE N/A
- ERNA N/A
- AVG Volume (30 Days)
- AMZE 125.5K
- ERNA 83.3K
- Earning Date
- AMZE 08-14-2025
- ERNA 08-13-2025
- Dividend Yield
- AMZE N/A
- ERNA N/A
- EPS Growth
- AMZE N/A
- ERNA N/A
- EPS
- AMZE N/A
- ERNA N/A
- Revenue
- AMZE $1,054,111.00
- ERNA $488,000.00
- Revenue This Year
- AMZE N/A
- ERNA N/A
- Revenue Next Year
- AMZE N/A
- ERNA N/A
- P/E Ratio
- AMZE N/A
- ERNA N/A
- Revenue Growth
- AMZE N/A
- ERNA 201.24
- 52 Week Low
- AMZE $2.72
- ERNA $1.50
- 52 Week High
- AMZE $28.72
- ERNA $28.80
- Technical
- Relative Strength Index (RSI)
- AMZE N/A
- ERNA 37.07
- Support Level
- AMZE N/A
- ERNA $1.62
- Resistance Level
- AMZE N/A
- ERNA $1.70
- Average True Range (ATR)
- AMZE 0.00
- ERNA 0.10
- MACD
- AMZE 0.00
- ERNA 0.01
- Stochastic Oscillator
- AMZE 0.00
- ERNA 20.73
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.